美文网首页
美国曼托(Mentor)公司的MemoryGel® XTRA硅胶

美国曼托(Mentor)公司的MemoryGel® XTRA硅胶

作者: 吴画不谈 | 来源:发表于2017-05-15 15:08 被阅读0次

    4月26日,美国曼托(Mentor)公司宣布其产品MemoryGel® XTRA硅胶乳房假体获FDA认证,将于美国市场内销售,该产品能够帮助乳房重塑、隆胸或矫正手术实现更好的丰满度与突度。

    Mentor® Announces FDA Approval for MemoryGel® XTRA Silicone Gel-Filled Breast Implants

    IRVINE, Calif., April 26, 2017 /PRNewswire/ -- Mentor Worldwide LLC,

    a global leader in breast aesthetics, today announced that it has

    received approval from the U.S. Food & Drug Administration (FDA) to

    market MemoryGel® Xtra silicone gel-filled breast implants in the U.S.

    The new addition to the company's top-selling global brand of breast

    implants offers extra fullness and projection to women undergoing breast

    reconstruction, augmentation or revision surgery.

    "I look

    forward to being able to provide women with this new style of implant to

    consider, as they evaluate the options associated with breast implant

    surgery," said Dr. Louis Strock,* American Board of Plastic Surgery,

    Diplomate. "MENTOR® MemoryGel® implants, with their soft, natural feel,

    have been a great fit for many of my patients throughout the years. Each

    enhancement to the MemoryGel product line has been thoughtfully

    designed with patients in mind."

    MENTOR® MemoryGel® Xtra implants will soon be available to customers in the U.S.

    ARTOURA Breast Tissue Expander with a Smooth Shell

    The company also announced a new addition to its ARTOURA Breast

    Tissue Expander line, an expander with a smooth shell that will be

    available throughout the U.S. This product widens options for

    reconstructive surgeries and provides an alternative for surgeons who

    may prefer a smooth expander.

    The MENTOR® ARTOURA Breast

    Tissue Expander is the only expander with Dynamic Control Technology

    designed to provide a precise, controlled expansion. The reliable,

    contoured MENTOR® ARTOURA Breast Tissue Expander simplifies expander

    selection and provides a more seamless transition to final implant

    selection.

    "Since its launch in 2015, the MENTOR® ARTOURA

    expander platform has proven to be a welcome innovation in breast tissue

    expander technology," said Dr. Salvatore J. Pacella,* Division Head,

    Plastic Surgery Scripps Clinic and Green Hospital in La Jolla,

    California. "Having a new smooth shell configuration, in addition to the

    existing SILTEX® textured shell, gives me the ability to select an

    appropriately surfaced expander for my patients, which has previously

    not been available. I've continued to add the smooth-shelled ARTOURA

    Expander into my practice and have been very pleased with the

    performance of the device, particularly with the final aesthetic result

    after expander-to-implant exchange."

    The ARTOURA Expander is

    available in two projections and achieves a full profile at a range of

    fill volumes which enables a match with corresponding MemoryShape® and

    MemoryGel® Breast Implant options.

    About Mentor Worldwide LLC

    Mentor Worldwide LLC, part of Johnson & Johnson Medical Devices

    Companies, is a leading supplier of breast implants in the global

    aesthetic market. The company develops, manufactures, and markets

    innovative, science-based products for surgical and non-surgical medical

    procedures that allow breast surgery patients to improve their quality

    of life. The company is focused on two strategic areas: breast

    reconstruction and breast augmentation. MENTOR® is the only manufacturer

    whose silicone breast implants are made in the U.S.A. For more

    information about MENTOR® visit: www.mentorwwllc.com

    Important Safety Information:

    The MENTOR® Collection of Breast Implants are indicated for breast reconstruction.

    Breast implant surgery should not be performed in women:

    With active infection anywhere in their body

    With existing cancer or pre-cancer of their breasts who have not received adequate treatment for those conditions

    Who are currently pregnant or nursing

    Safety and effectiveness have not been established in patients with

    autoimmune diseases (for example lupus and scleroderma), a weakened

    immune system, conditions that interfere with wound healing and blood

    clotting, or reduced blood supply to breast tissue. Patients with a

    diagnosis of depression, or other mental health disorders, should wait

    until resolution or stabilization of these conditions prior to

    undergoing breast implantation surgery.

    There are risks

    associated with breast implant surgery. You should be aware that breast

    implants are not lifetime devices and breast implantation may not be a

    one-time surgery. You may need additional unplanned surgeries on your

    breasts because of complications or unacceptable cosmetic outcomes. Many

    of the changes to your breast following implantation are irreversible

    (cannot be undone) and breast implants may affect your ability to

    breastfeed, either by reducing or eliminating milk production.

    Breast implants are not lifetime devices and breast implantation may not be a one-time surgery.

    The most common complications for breast reconstruction with MENTOR®

    MemoryGel® Breast Implants include any reoperation, implant removal

    with or without replacement, and capsular contracture.

    The

    most common complications with MENTOR® MemoryShape® Breast Implants for

    breast reconstruction include reoperation for any reason, implant

    removal with or without replacement, and capsular contracture. A lower

    risk of complication is rupture. The health consequences of a ruptured

    silicone gel breast implant have not been fully established. MRI

    screenings are recommended three years after initial implant surgery and

    then every two years after to detect silent rupture.

    The most

    common complications for breast reconstruction with MENTOR®

    Saline-filled Breast Implants include reoperation, implant removal,

    capsular contracture, breast pain, and implant deflation.

    Detailed information regarding the risks and benefits associated with

    MENTOR® Breast Implants is provided in several educational brochures.

    For MemoryGel® Implants: Important Information for Reconstruction

    Patients about MENTOR® MemoryGel® Breast Implants. For MemoryShape®

    Implants: Patient Educational Brochure – Breast Reconstruction with

    MENTOR® MemoryShape® Breast Implants and Quick Facts about Breast

    Augmentation & Reconstruction with MENTOR® MemoryShape® Breast

    Implants. For MENTOR® Saline-filled Implants: Saline-Filled Breast

    Implants: Making an Informed Decision. These brochures are available

    from your surgeon or visit www.mentorwwllc.com. It is important that you

    read and understand these brochures when considering MENTOR® Breast

    Implants.

    The CONTOUR PROFILE® Breast Tissue Expander can be

    utilized for breast reconstruction after mastectomy, correction of an

    underdeveloped breast, scar revision, and tissue defect procedures. The

    expander is intended for temporary subcutaneous or submuscular

    implantation and is not intended for use beyond six months. CONTOUR

    PROFILE® Expanders should not be used in patients where an MRI may be

    needed. The device could be moved by the MRI causing pain or

    displacement, potentially resulting in a revision surgery. The incidence

    of extrusion of the expander has been shown to increase when the

    expander has been placed in injured areas. Detailed information about

    indications, contraindications, warnings, and precautions associated

    with the use of CONTOUR PROFILE® Expanders are provided in the Product

    Insert Data Sheet available online at www.mentorwwllc.com.

    * Dr. Strock and Dr. Pacella are paid consultants to Mentor Worldwide LLC.

    49岁女性脂肪填充上睑后睑下垂10个月,脂肪源自自身大腿内侧,共计进行了两次注射,剂量未知。第二次注射后,出现双侧眼睑下垂。8个月时,对右侧眼睑进行过矫正手术,略有改善。之后就诊于本文作者,并进行了脂肪移除与推进上眼提肌筋膜。(AB)治疗前,检测发现左、右侧提肌分别偏移6mm与7mm;(CD)手术中,两个眼睑腱膜前区域有“脂肪团”,且纤维与周围组织连结(白箭头)。释放纤维并切除部分脂肪,待患者清醒后要求其睁开眼睛,评估是否推进上眼提肌筋膜,最终该患者右侧上眼提肌筋膜推进10mm,左侧推进8mm;(E)术后4天,效果可接受;(F)3个半月后发现左右不对称,左侧矫正不足,右侧矫正过度,而后对右侧进行了“释放”;(G)首次下垂矫正5个月后,患者左侧上眼提肌筋膜又推进2mm;(H)术后1年

    相关文章

      网友评论

          本文标题:美国曼托(Mentor)公司的MemoryGel® XTRA硅胶

          本文链接:https://www.haomeiwen.com/subject/bahhnttx.html